Cargando…

Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials

Capsular contracture is an important complication after silicone mammary implant surgery. Fibroblasts and macrophages play critical roles in the pathogenesis of capsular contracture, making these two cell types therapeutic targets. It has been reported that inhibiting histamine receptors results att...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Litong, Wang, Tie, Tian, Lining, Song, Hongjiang, Gao, Meizhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896367/
https://www.ncbi.nlm.nih.gov/pubmed/31746427
http://dx.doi.org/10.3892/mmr.2019.10815
_version_ 1783476763056144384
author Ji, Litong
Wang, Tie
Tian, Lining
Song, Hongjiang
Gao, Meizhuo
author_facet Ji, Litong
Wang, Tie
Tian, Lining
Song, Hongjiang
Gao, Meizhuo
author_sort Ji, Litong
collection PubMed
description Capsular contracture is an important complication after silicone mammary implant surgery. Fibroblasts and macrophages play critical roles in the pathogenesis of capsular contracture, making these two cell types therapeutic targets. It has been reported that inhibiting histamine receptors results attenuates fibrosis, but the role of roxatidine (a histamine receptor 2 inhibitor) in preventing fibrosis caused by breast implant materials remains unknown. The aim of the present study was to assess the hypothesis that roxatidine might have a prophylactic effect in capsular contracture induced by implant material. Inflammation induced by breast implant materials was mimicked by co-culturing macrophages or fibroblasts with these materials in vitro. Capsular contracture was modeled in mice by planting breast implant materials in a subcutaneous pocket. Roxatidine was added in the culture medium or administered to mice bearing breast implant materials. By co-culturing macrophages or fibroblasts with common breast implant materials (micro-textured or smooth breast implants), the present study demonstrated that macrophages respond to these materials by producing pro-inflammatory cytokines, a process that was abolished by addition of roxatidine to the culture medium. Although fibroblasts did not respond to implant surface materials in the same way as macrophages, the conditioned media of macrophages induced proliferation of fibroblasts. Mechanistically, administration of roxatidine inhibited activation of NF-κB and p38/mitogen-activated protein kinase (MAPK) signaling in macrophages. Furthermore, treatment with roxatidine in implant-bearing mice reduced serum concentrations of transforming growth factor-β and the abundance of fibroblasts around the implant. The present study concluded that roxatidine plays an important role in preventing fibrosis by inhibiting activation of NF-κB and p38/MAPK signaling in macrophages.
format Online
Article
Text
id pubmed-6896367
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-68963672019-12-09 Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials Ji, Litong Wang, Tie Tian, Lining Song, Hongjiang Gao, Meizhuo Mol Med Rep Articles Capsular contracture is an important complication after silicone mammary implant surgery. Fibroblasts and macrophages play critical roles in the pathogenesis of capsular contracture, making these two cell types therapeutic targets. It has been reported that inhibiting histamine receptors results attenuates fibrosis, but the role of roxatidine (a histamine receptor 2 inhibitor) in preventing fibrosis caused by breast implant materials remains unknown. The aim of the present study was to assess the hypothesis that roxatidine might have a prophylactic effect in capsular contracture induced by implant material. Inflammation induced by breast implant materials was mimicked by co-culturing macrophages or fibroblasts with these materials in vitro. Capsular contracture was modeled in mice by planting breast implant materials in a subcutaneous pocket. Roxatidine was added in the culture medium or administered to mice bearing breast implant materials. By co-culturing macrophages or fibroblasts with common breast implant materials (micro-textured or smooth breast implants), the present study demonstrated that macrophages respond to these materials by producing pro-inflammatory cytokines, a process that was abolished by addition of roxatidine to the culture medium. Although fibroblasts did not respond to implant surface materials in the same way as macrophages, the conditioned media of macrophages induced proliferation of fibroblasts. Mechanistically, administration of roxatidine inhibited activation of NF-κB and p38/mitogen-activated protein kinase (MAPK) signaling in macrophages. Furthermore, treatment with roxatidine in implant-bearing mice reduced serum concentrations of transforming growth factor-β and the abundance of fibroblasts around the implant. The present study concluded that roxatidine plays an important role in preventing fibrosis by inhibiting activation of NF-κB and p38/MAPK signaling in macrophages. D.A. Spandidos 2020-01 2019-11-12 /pmc/articles/PMC6896367/ /pubmed/31746427 http://dx.doi.org/10.3892/mmr.2019.10815 Text en Copyright: © Ji et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Ji, Litong
Wang, Tie
Tian, Lining
Song, Hongjiang
Gao, Meizhuo
Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title_full Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title_fullStr Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title_full_unstemmed Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title_short Roxatidine inhibits fibrosis by inhibiting NF-κB and MAPK signaling in macrophages sensing breast implant surface materials
title_sort roxatidine inhibits fibrosis by inhibiting nf-κb and mapk signaling in macrophages sensing breast implant surface materials
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896367/
https://www.ncbi.nlm.nih.gov/pubmed/31746427
http://dx.doi.org/10.3892/mmr.2019.10815
work_keys_str_mv AT jilitong roxatidineinhibitsfibrosisbyinhibitingnfkbandmapksignalinginmacrophagessensingbreastimplantsurfacematerials
AT wangtie roxatidineinhibitsfibrosisbyinhibitingnfkbandmapksignalinginmacrophagessensingbreastimplantsurfacematerials
AT tianlining roxatidineinhibitsfibrosisbyinhibitingnfkbandmapksignalinginmacrophagessensingbreastimplantsurfacematerials
AT songhongjiang roxatidineinhibitsfibrosisbyinhibitingnfkbandmapksignalinginmacrophagessensingbreastimplantsurfacematerials
AT gaomeizhuo roxatidineinhibitsfibrosisbyinhibitingnfkbandmapksignalinginmacrophagessensingbreastimplantsurfacematerials